Commonwealth Equity Services LLC raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 6.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,615 shares of the company’s stock after purchasing an additional 533 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Henry Schein were worth $676,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Mission Wealth Management LP grew its stake in shares of Henry Schein by 4.4% during the 4th quarter. Mission Wealth Management LP now owns 4,329 shares of the company’s stock valued at $340,000 after acquiring an additional 182 shares during the period. Wilbanks Smith & Thomas Asset Management LLC lifted its holdings in Henry Schein by 5.9% in the 4th quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 3,368 shares of the company’s stock worth $264,000 after purchasing an additional 189 shares in the last quarter. Securian Asset Management Inc lifted its holdings in Henry Schein by 1.4% in the 4th quarter. Securian Asset Management Inc now owns 15,498 shares of the company’s stock worth $1,217,000 after purchasing an additional 221 shares in the last quarter. Advisor Partners LLC lifted its holdings in Henry Schein by 6.6% in the 4th quarter. Advisor Partners LLC now owns 3,796 shares of the company’s stock worth $298,000 after purchasing an additional 234 shares in the last quarter. Finally, Contravisory Investment Management Inc. lifted its holdings in Henry Schein by 5.8% in the 4th quarter. Contravisory Investment Management Inc. now owns 4,737 shares of the company’s stock worth $372,000 after purchasing an additional 259 shares in the last quarter.
A number of research firms recently commented on HSIC. Robert W. Baird reissued a “neutral” rating on shares of Henry Schein in a report on Monday, March 25th. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a report on Tuesday, January 8th. BidaskClub cut Henry Schein from a “strong-buy” rating to a “buy” rating in a report on Friday, January 4th. Barclays lowered their price target on Henry Schein from $73.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, February 21st. Finally, Evercore ISI cut Henry Schein from an “in-line” rating to an “underperform” rating and set a $76.39 price target on the stock. in a report on Thursday, January 3rd. Seven research analysts have rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $79.87.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Wednesday, February 20th. The company reported $1.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.01. Henry Schein had a return on equity of 19.86% and a net margin of 4.06%. The business had revenue of $3.38 billion for the quarter, compared to analysts’ expectations of $3.46 billion. During the same period in the prior year, the firm earned $0.97 EPS. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. On average, sell-side analysts expect that Henry Schein, Inc. will post 3.43 earnings per share for the current year.
In other Henry Schein news, Director Philip A. Laskawy sold 1,084 shares of the company’s stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $59.86, for a total value of $64,888.24. Following the transaction, the director now owns 32,899 shares of the company’s stock, valued at approximately $1,969,334.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 3,591 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $59.12, for a total value of $212,299.92. The disclosure for this sale can be found here. Corporate insiders own 1.15% of the company’s stock.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also: Understanding Options Trading
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.